|  | Number and 1-month survival rate (%) | χ 2 value | P value | |||
---|---|---|---|---|---|---|---|
 |  | Group 1 | Group 2 |  |  | ||
1 | ≤1(Group 1)/≥2(Group 2) | 3003 | (35.74%) | 3477 | (27.93%) | 142.68 | <0.0001 |
2 | ≤2(Group 1)/≥3(Group 2) | 4677 | (34.48%) | 1803 | (24.75%) | 209.61 | <0.0001 |
3 | ≤3(Group 1)/≥4(Group 2) | 5616 | (33.15%) | 864 | (22.11%) | 180.63 | <0.0001 |
4 | ≤4(Group 1)/≥5(Group 2) | 6065 | (32.48%) | 415 | (19.06%) | 163.82 | <0.0001 |
5 | ≤5(Group 1)/≥6(Group 2) | 6260 | (31.86%) | 220 | (18.29%) | 97.50 | <0.0001 |
6 | ≤6(Group 1)/≥7(Group 2) | 6374 | (31.48%) | 106 | (17.49%) | 53.78 | <0.0001 |
7 | ≤7(Group 1) ≥8(Group 2) | 6425 | (31.34%) | 55 | (15.71%) | 39.23 | <0.0001 |
8 | ≤8(Group 1)/≥9(Group 2) | 6454 | (31.25%) | 26 | (13.13%) | 30.06 | <0.0001 |
9 | ≤9(Group 1)/≥10(Group 2) | 6464 | (31.18%) | 16 | (13.11%) | 18.49 | <0.0001 |